CAR-T therapy is a groundbreaking treatment that modifies a patient’s T cells to better recognize and attack cancer cells. It’s like giving your immune system a superhero upgrade!Â
CAR-T therapy is currently approved for certain blood cancers, such as B-cell acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Research is ongoing for its use in solid tumors.Â
Yes. While CAR-T therapy was originally developed for cancer, researchers are now exploring its potential in treating autoimmune diseases by targeting specific immune cells involved in the disease process.Â